| Ytd | -47.37% | |
| 1y | -20.18% |
| Open | 1.57 | Prev Close | 1.60 | Low | 1.57 | High | 1.73 | Mkt Cap | 4.32M |
| Vol | 11.03K | Avg Vol | 14.36K | EPS | -1.75 | P/E | N/A | Forward P/E | -3.25 |
| Beta | -1.00 | Short Ratio | 10.12 | Inst. Own | 12.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.99 | 200-d Avg | 2.73 | 1yr Est | 1.75 |
TCRT News
Gainers VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market
This statistical finding supports a lower liver-weight signal after adjustment for body fat percenta
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&
ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, includin
ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, includin
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) today announced updated preclinical data from non-GLP diet-
FORT LAUDERDALE, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) to
Seasoned Biopharmaceutical Attorney with Deep IP, Clinical-Stage, and Nasdaq Public Company Experien
Alaunos Therapeutics Inc. (NASDAQ: TCRT) shares are down on Monday after the company announced precl
The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body compositio
Alaunos' ALN1003 shows dose dependent weight loss, better body composition, reduced liver weight, an
Alaunos Therapeutics, Inc. (NASDAQ: TCRT - Get Free Report) saw a significant decline in short inter
Alaunos Therapeutics, Inc. (NASDAQ: TCRT - Get Free Report) was up 3.1% during mid-day trading on We
Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names h
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.63) per share. This is a 11.27 p
HOUSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) (the “Company”)
PMGC Capital LLC ("PMGC Capital"), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ:E
NEWPORT BEACH, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital”), a wholly
NEWPORT BEACH, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital,” “we,” “our
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company rep
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead an
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the comp
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the
Alaunos Therapeutics (NASDAQ: TCRT ) stock is up on Monday despite a lack of news from the clinical-